Cepheid (NASDAQ:CPHD)

CAPS Rating: 3 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar Wakiday2 (87.08) Submitted: 6/17/2010 8:29:44 AM : Outperform Start Price: $18.40 CPHD Score: +91.42

projected earnings 12mo

Featured Broker Partners


Advertisement